These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes. Poulos A; Sharp P; Johnson D Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697 [TBL] [Abstract][Full Text] [Related]
10. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction. Singh AK; Kulvatunyou N; Singh I; Stanley WS Hum Hered; 1989; 39(5):298-301. PubMed ID: 2482247 [TBL] [Abstract][Full Text] [Related]
11. Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders. Hughes JL; Poulos A; Robertson E; Chow CW; Sheffield LJ; Christodoulou J; Carter RF Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):255-64. PubMed ID: 1689088 [TBL] [Abstract][Full Text] [Related]
12. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants. Poulos A; Singh H; Paton B; Sharp P; Derwas N Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264 [TBL] [Abstract][Full Text] [Related]
13. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders. Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624 [TBL] [Abstract][Full Text] [Related]
14. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids. Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868 [TBL] [Abstract][Full Text] [Related]
15. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders]. Suzuki Y No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633 [TBL] [Abstract][Full Text] [Related]
16. Refsum's disease, adrenoleucodystrophy, and the Zellweger syndrome. Stokke O; Skrede S; Ek J; Björkhem I Scand J Clin Lab Invest; 1984 Sep; 44(5):463-4. PubMed ID: 6207587 [No Abstract] [Full Text] [Related]
17. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect. Guerroui S; Aubourg P; Chen WW; Hashimoto T; Scotto J Biochem Biophys Res Commun; 1989 May; 161(1):242-51. PubMed ID: 2471528 [TBL] [Abstract][Full Text] [Related]
18. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849 [TBL] [Abstract][Full Text] [Related]
19. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Hughes JL; Crane DI; Robertson E; Poulos A Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):459-68. PubMed ID: 7507276 [TBL] [Abstract][Full Text] [Related]
20. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]